After Bharat Biotech making a breakthrough and entering into human trials, 2 more possible COVID vaccines go into the initial stages of human trials. Ahmedabad based Zydus Cadila has been given the green light to begin Phase I and II human trials of another coronavirus vaccine candidate. This is the second coronavirus vaccine to get approval for human trials in India. Novel coronavirus infections continue to climb here with India becoming the world’s fourth worst-hit nation.
With drug manufacturers across the world scrambling to develop a vaccine for Covid-19, the disease caused by the novel coronavirus, Ahmedabad-based Zydus Cadila said it has received approval from the Drugs Controller General of India (DCGI) to conduct human studies for its coronavirus vaccine candidate.
However, no vaccine has yet been approved for commercial use against coronavirus in the world but more than a dozen from over 100 candidates globally are currently being tested on humans.
Source: Drugs Controller General of India (DCGI)